MedPath
TGA Approval

ONIVYDE irinotecan (as sucrosofate) 43 mg/10 mL nanoliposomal concentrated injection for infusion (263184)

263184

ONIVYDE irinotecan (as sucrosofate) 43 mg/10 mL nanoliposomal concentrated injection for infusion

Servier Laboratories (Aust) Pty Ltd

December 19, 2016

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/b2c4b11a6070db4582331e3a55819199.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/0e2e3b907e4aed28032a3dffa5455654.pdf

Active Ingredients

irinotecan hydrochloride trihydrate

© Copyright 2025. All Rights Reserved by MedPath